Pemphigus
📧 Sign up to get email alerts when something new happens for Pemphigus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-10-23Clinical Trial Update: The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
An observational ClinicalTrials.gov update (RITAI Cohort) investigates off-label use of rituximab for autoimmune disorders, including pemphi…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab [Phase 3]
This is a Phase 3 trial update on long-term outcomes for patients with severe pemphigus treated with rituximab. The study reports clinical a…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex [NA]
Clinical trial update investigating treating pemphigus with rituximab 1000 mg given twice and assessing immune status using the Cylex test.
-
CLINICAL_TRIALS trial_result · 2008-10-02Clinical Trial Update: Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus [Phase 2]
A Phase II clinical trial evaluating high-dose cyclophosphamide in patients with refractory pemphigus has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-30Clinical Trial Update: European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus [Phase 2, Phase 3]
European Phase 2/3 trial of adjuvant oral glucocorticoid pulse therapy for pemphigus has completed; no results are summarized in the documen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.